HS-20122

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-20122, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-20122 in Patients With Advanced Solid Tumors [Phase 1]